Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT

Condition:   Hyperparathyroidism; Secondary, Renal Intervention:   Drug: Cinacalcet HCl Sponsor:   Kyowa Hakko Kirin China Pharmaceutical Co.,LTD. Not yet recruiting - verified April 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials